medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2014, Number 1

<< Back Next >>

Rev Mex Patol Clin Med Lab 2014; 61 (1)

Behavior of serum cortisol in diabetic patients treated with floral therapy

Mahia VM, Díaz BA, Alonso C, García MM, Hernández CJ, Ramos MLE

Language: Spanish
References: 25
Page: 47-51
PDF size: 461.00 Kb.


ABSTRACT

Background: Diabetes mellitus is a major health problem worldwide for being one of the most common non-communicable diseases, as well as for the severity of its complications. Cortisol is hyper secreted in chronic form during diabetes and in some emotional states such as stress, contributing to increased blood glucose and thus making metabolic control unmanageable. Objective: To determine the behavior of serum cortisol levels in diabetic patients treated with floral therapy. Subjects and methods: We studied 200 type 2 diabetic outpatients without clinical diabetic foot, divided into two groups: a study group that received floral treatment and a control group receiving placebo treatment. The patients studied were of either sex, aged between 40 and 78 years old, with over 10 years of evolution of the disease, to whom cortisol levels determinations and serum glucose levels were performed on an empty stomach. Determinations were performed before and after floral and placebo treatment. Results: When initiating treatment, high levels of cortisol in serum and metabolic lack of control were found in all patients. After treatment, the study group that received floral treatment significantly decreased both cortisol levels and their serum glucose. These results were not found in the group that received placebo. Conclusions: The role of normocortisolemia levels in type 2 diabetic individuals is important to maintain metabolic control; this has been achieved by using a floral treatment. Among natural therapies, floral stands out as a therapy that uses energy pathways to achieve harmonization of emotional states.


REFERENCES

  1. Álvarez AA, González SR, Marrero FM. Role of testosterone and cortisol in metabolic syndrome and type 2 diabetes mellitus Rev Cubana Endocrinol. 2010; 21: 80-90.

  2. Kriegsfeld LJ, Silver R. The regulation of neuroendocrine function: timing is everything. Hormones and Behaviour. 2006; 49: 557-574.

  3. Van Cauter E, Leproult R, Kupfer DJ. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab. 1996; 81: 2468-2473.       

  4. Felšöci M, Schroner Z, Petrovičová J, Lazúrová I. Relationship between type 2 diabetes mellitus and hypothalamic-pituitary-adrenal axis. Wien Klin Wochenschr. 2011; 123: 28-33.

  5. Liu H, Bravata DM, Cabaccan J, Raff H, Ryzen E. Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clin Endocrinol. 2005; 63: 642-649.        

  6. Lederbogen F, Hummel J, Fademrecht C, Krumm B, Kühner C, Deuschle M et al. Flattened circadian cortisol rhythm in type 2 diabetes. Exp Clin Endocrinol Diabetes. 2011; 119: 573-575.

  7. Mahia VM, Diaz BA, Garcia MM, Hernandez CJ, Alonso C. Estudio de los niveles de cortisol sérico en pacientes con diabetes mellitus tipo 2. Rev Mex Patol Clin. 2009; 4: 90-94.

  8. Kalagina LS. Clinical value of serum cortisol determination. Klin Lab Diagn. 2011; 2: 23-25.

  9. Valdés RE, Bencosme RN. The macrovascular complications and its relation to some clinical and biochemical variables in type 2 diabetes patients. Rev Cubana Endocrinol. 2010; 21: 256-268. 

  10. Monteiro-Soares M, Vaz CA, Sampaio S, Dinis-Ribeiro M. Validation and comparison of currently available stratification systems for patients with diabetes by risk of foot ulcer development. Eur J Endocrinol. 2012; 167: 401-407.

  11. Socarrás SM, Blanco AJ, Vázquez VA. Factores de riesgo de enfermedad aterosclerótica en la diabetes mellitus tipo 2. Rev Cubana Med. 2003; 42: 108-112.

  12. Ayalon L, Gross R, Tabenkin H, Porath A, Heymann A, Porter B. Quality of life in primary care patients with diabetes: implications for social workers. Health Soc Work [serie en internet]. 2008; 33 (3). Disponible en: http://search.ebscohost.com/login.aspx?direct=true&db=mnh&AN=18773798&loginpage=Login.asp&site=ehost-live [Consultado: 8 Sept 2010].

  13. Vicente SB, Zerquera TG, Peraza AD, Castañeda AE, Irizar HJ, Bravo VT. Life quality of diabetic patients. Medisur. 2008; 6: 20-26.

  14. Fisher L, Skaff MM, Mullan JT, Arean P, Mohr D, Masharani U, et al. Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics. Diabetes Care. 2007; 30: 542-548.

  15. Gragnoli C. Depression and type 2 diabetes: cortisol pathway implication and investigational needs. J Cell Physiol. 2012; 227: 2318-2322.

  16. González Gómez SR. Diabetes Mellitus. Rev Cubana Med Gen Integr. [serie en Internet] 2005; 44. Disponible en: http://scielo.sld.cu/scielo.php ?script-sciartestepid-5004-75 [Consultado: 26 marzo 2007].

  17. American Diabetes Association: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2001; 24: 5-20.

  18. Leary B. The early work of Dr. Edward Bach. Br Homeopath J. 1999; 88: 28-30.

  19. La Torre MA. Integrative perspectives. Integrating Bach flower remedies into a therapeutic practice. Perspect Psychiatry Care. [serie en Internet] 2006; 42(2). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/16677139 [consultado: 20 Jul 2008]

  20. Cruz M. La Terapia Floral de Bach. MEDISAN. 2000; 4: 68-74.

  21. Vermeulen A, Van der Straden M. Determination of plasma cortisol by a fluorometric method. J Clin Endocr. 1964; 24: 1188-1194.

  22. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem. 1969; 6: 24-25.

  23. Sitio Web SEDIBAC. Disponible en: http://www.sedibac.org [Consultado: 6 sept 2008]

  24. Lima SA. Terapia floral en diabetes mellitus. SEDIBAC. [serie en internet] 2004. Disponible en: http://www.sedibac.org/temas/tema.%20diabetes%20mellitus.pdf [consultado: 6 Sept 2008]

  25. Tsigos C, Chrousos G. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psycho Res. 2002; 55: 865-871.




2020     |     www.medigraphic.com